LNC
SNY icon

Lincoln National Corp’s Sanofi SNY Stock Holding History

Lincoln National Corp’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,112
Closed -$443K – 968
2024
Q1 		$443K Buy
9,112
+3,550
+64% +$173K 0.01% 797
2023
Q4 		$277K Sell
5,562
-259
-4% -$12.7K ﹤0.01% 908
2023
Q3 		$312K Sell
5,821
-2
-0% -$107 0.01% 767
2023
Q2 		$314K Sell
5,823
-46
-0.8% -$2.48K 0.01% 768
2023
Q1 		$319K Buy
5,869
+122
+2% +$5.93K 0.01% 744
2022
Q4 		$278K Buy
5,747
+338
+6% +$14.8K 0.01% 744
2022
Q3 		$206K Buy
5,409
+200
+4% +$8.91K 0.01% 808
2022
Q2 		$261K Buy
5,209
+989
+23% +$52.5K 0.01% 706
2022
Q1 		$217K Buy
+4,220
New +$218K ﹤0.01% 837

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Lincoln National Corp's SNY Position: Q2 2024 in Review

Lincoln National Corp sold out of Sanofi (SNY) in Q2 2024, closing a stake of 9,112 shares — an estimated $443K sold.

Lincoln National Corp first reported a position in SNY in Q1 2022 and held it in 9 quarters. The position peaked at $443K in Q1 2024. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

  • Lincoln National Corp reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 9,112 Sanofi shares in Q2 2024, an estimated $443K.
  • Lincoln National Corp first reported a position in Sanofi in Q1 2022 and held it in 9 quarters.
  • Lincoln National Corp's Sanofi position peaked at $443K in Q1 2024.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.